A Kyiv biotechnology enterprise running two clinics and a cord blood bank, offering stem cell and tissue therapy with Ukrainian ministry approval for two named products.
The Institute of Cell Therapy is a Ukrainian biotechnology enterprise in Kyiv that combines a cryobank with clinical treatment. Its site says the cryobank was created in 2003 and its first clinic opened in 2004, with a second Kyiv clinic added in 2018. It gives two Kyiv addresses, on Liubomyra Husara Avenue and on Mokra Street.
According to the site, the institute treats patients with stem cells drawn from a range of sources — bone marrow and cord blood, and also placenta, fat tissue, umbilical cord tissue, amniotic fluid and the pulp of milk teeth. It describes several routes of administration, including intravenous infusion, injection directly into damaged tissue, transplantation into bone and a cardiac procedure it calls cellular cardiomyoplasty.
The site states that the institute holds a state licence, granted in 2008, for clinical investigation of stem cells, and that in 2012 the Ukrainian Ministry of Health approved two of its treatments, marketed as Pancrostem and Angiostem. It also states compliance with the ISO 9001:2015 quality management standard and membership of several professional bodies, among them the International Society for Cell and Gene Therapy, the International Society for Stem Cell Research and, since 2020, the Cord Blood Association.
The site makes a broad claim that stem cells are successfully used in the treatment of about one hundred serious diseases, and names cardiovascular conditions, traumatic injury, autoimmune disease, complications of cancer treatment, type 1 diabetes and recovery from COVID-19 using placenta-derived mesenchymal stem cells. That figure is the institute's own statement and is not verified here; only two of its treatments are described as having ministry approval. The site names no individual clinicians.
The site names the following among the conditions it treats, while claiming a much wider range overall.
The site says the institute uses stem cells from several different tissues, chosen according to the treatment, and delivers them by infusion, local injection or transplantation into bone.
The site refers to its specialists collectively but names no individual clinician on the pages read.
The institute operates two clinics in Kyiv, at 3 Liubomyra Husara Avenue and 9 Mokra Street, open Monday to Friday from 09:00 to 18:00 and closed at weekends, alongside a cryobank for storing cord blood and tissue. The site states compliance with ISO 9001:2015 and a state licence for clinical stem cell investigation granted in 2008, and lists membership of several international professional societies.
The site does not publish prices; it offers a consultation form for enquiries about services and costs.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.